Related Experiment Video
Updated: Jun 8, 2025
07:46
Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa
Published on: October 22, 2015
14.4K
Antipsychotic drugs for anorexia nervosa
Kazufumi Yoshida1, Hissei Imai1,2, Ethan Sahker1,3
1Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.
The Cochrane Database of Systematic Reviews
|November 6, 2024
Summary
This review protocol examines antipsychotic drugs versus placebo for anorexia nervosa. It will assess impacts on weight gain, psychological symptoms, and adverse events in patients.
Area of Science:
- Psychiatry and Clinical Psychology
- Pharmacology and Therapeutics
Background:
- Anorexia nervosa is a severe eating disorder with significant physical and psychological morbidity.
- Current treatment options for anorexia nervosa have limited efficacy, necessitating exploration of pharmacological interventions.
Purpose of the Study:
- To systematically review the efficacy and safety of antipsychotic medications in treating anorexia nervosa.
- To compare the effects of first- and second-generation antipsychotics against placebo on key outcomes.
Main Methods:
- This protocol outlines a Cochrane Review of randomized controlled trials.
- The review will include studies assessing antipsychotic drugs (first- and second-generation) versus placebo.
- Outcomes of interest include body weight changes, psychological symptom severity, treatment acceptability, and adverse events.
Main Results:
- This section will present findings from the systematic review once studies are identified and data are extracted.
- Results will focus on the comparative effectiveness and safety of antipsychotics in anorexia nervosa.
Conclusions:
- This review aims to provide evidence-based guidance on the use of antipsychotic drugs for anorexia nervosa.
- Findings will inform clinical practice and future research directions in managing this complex disorder.
Related Concept Videos
01:28Psychosis and Antipsychotic Drugs: Overview
183
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
183
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
122
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
122
01:26Psychosis: Goals of Pharmacotherapy
104
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
104
01:21Antipsychotic Drugs: Typical and Atypical Agents
157
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
157
01:23Antidepressant Drugs: MAOIs and Other Agents
196
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
196
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
227
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
227